Owner/Developer: Selvita S.A.
Selvita is a drug discovery company engaged in the research and development of breakthrough therapies primarily in the area of oncology, as well as provision of integrated drug discovery services. The company was established in 2007 and currently employs over 340 scientists, among which 30% are PhDs. Selvita offers integrated drug discovery projects helping biotech and pharma partners discover and develop new drugs. Our scientists have an extensive experience in several areas of life sciences. Selvita specializes in a broad spectrum of pharmacodynamic in vitro studies used to analyze biosimilar product's activity in comparison to adequate reference compounds. We offer assays that are able to detect even minor changes in biological response to pharmacologically active substances. EU-NETVAL member.
|Channel:||Website - Audio / Video - Social media - Professional online network|
|Relevance:||Replacement - Reduction|
|Purpose:||Fundamental studies - Toxicological and safety evaluation - Efficacy testing - Regulatory testing - Validation - Method development|
|Technology/Tools:||High throughput screening - Non-testing methods (in silico) - Omics - Alternative test methods (in vitro)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!Please contact us by email if you have any questions.